MINITRAN TTS 10 mg/24h 30 pce

7680519200585 CH-51920 C01DA02 02.04.1.
MINITRAN TTS 10 mg/24h 30 pce
MINITRAN TTS 10 mg/24h 30 pce
MINITRAN TTS 10 mg/24h 30 pce
1 / 3
google

Details

Product number
5192002
CPT
-
Packaging group
30
Unit
Pflaster
Composition
glyceroli trinitras 36 mg, isooctyl acrylate/acrylamide copolymer (93:7), ethylis oleas, glyceroli monolauras, polyethylenum, ad praeparationem pro 13.3 cm², cum liberatione 10 mg/24h.

Articles (1)

Minitran 10, transdermales Pflaster
Transdermales Pflaster
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/10/2023
Patient information leaflet
Français
02/10/2023
Patient information leaflet
Italien
02/10/2023
Professional SmPC
Allemand
02/10/2023
Professional SmPC
Français
02/10/2023
Professional SmPC
Italien
02/10/2023

Detailed composition

Substance Quantity Type Category
(N/A)
36.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
51920
Drug name
Minitran, transdermales Pflaster
Galenic form
TRAP
ATC Code
C01DA02
Authorization status
Z
Dispensation category
B
First authorization
22/01/1993
Authorization expiration date
31/12/9999
IT number
02.04.1.
Domain
Human medicine
Field of application
Koronartherapeutikum aus der Klasse der organischen Nitrate

Packaging details

Description (FR)
MINITRAN TTS 10 mg/24h 30 pce
Description (DE)
MINITRAN TTS 10 mg/24h 30 Stk
Market launch
22/01/1993
Narcotic (BTM)
No

Other packaging sizes

MINITRAN TTS 5 mg/24h 30 pce
30 PFLA
View